RENEE P. TANNENBAUM, PHARM.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Cardiff Oncology, Inc.

Filing Date Source Excerpt
2021-04-28 Dr. Tannenbaum currently serves as Vice President of Global Partnering at Halozyme, Inc... The Board believes that Dr. Tannenbaum’s extensive experience in the biopharmaceutical industry... provides her with the qualifications and skills to serve as a director.
2022-04-14 Dr. Tannenbaum received her Doctor of Pharmacy degree from the Philadelphia College of Pharmacy and Sciences, her MBA from Temple University, and her Bachelor of Science degree in Pharmacy from the University of Connecticut. The Board believes that Dr. Tannenbaum’s extensive experience in the biopharmaceutical industry... provides her with the qualifications and skills to serve as a director.
2023-04-27 Dr. Tannenbaum received her Doctor of Pharmacy degree from the Philadelphia College of Pharmacy and Sciences, her MBA from Temple University, and her Bachelor of Science degree in Pharmacy from the University of Connecticut.
2024-04-25 Dr. Tannenbaum received her Doctor of Pharmacy degree from the Philadelphia College of Pharmacy and Sciences, her MBA from Temple University, and her Bachelor of Science degree in Pharmacy from the University of Connecticut. The Board believes that Dr. Tannenbaum’s extensive experience in the biopharmaceutical industry, including providing strong executive leadership to numerous biopharmaceutical companies provides her with the qualifications and skills to serve as a director.

Data sourced from SEC filings. Last updated: 2026-02-03